Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Capital Expenditures (2016 - 2025)

InspireMD (NSPR) has 16 years of Capital Expenditures data on record, last reported at $329000.0 in Q3 2025.

  • For Q3 2025, Capital Expenditures fell 21.85% year-over-year to $329000.0; the TTM value through Sep 2025 reached $1.6 million, up 20.6%, while the annual FY2024 figure was $1.4 million, 267.98% up from the prior year.
  • Capital Expenditures reached $329000.0 in Q3 2025 per NSPR's latest filing, down from $576000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $576000.0 in Q2 2025 and bottomed at $25000.0 in Q1 2023.
  • Average Capital Expenditures over 5 years is $203368.4, with a median of $157000.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: plummeted 60.87% in 2023, then surged 955.56% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $107000.0 in 2021, then dropped by 11.21% to $95000.0 in 2022, then skyrocketed by 126.32% to $215000.0 in 2023, then skyrocketed by 44.65% to $311000.0 in 2024, then increased by 5.79% to $329000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $329000.0 in Q3 2025, $576000.0 in Q2 2025, and $359000.0 in Q1 2025.